Prevention of post-contrast kidney injury in patients with cancer.
cancer
computed tomography
post-contrast acute kidney injury
Journal
Drugs in context
ISSN: 1745-1981
Titre abrégé: Drugs Context
Pays: England
ID NLM: 101262187
Informations de publication
Date de publication:
2024
2024
Historique:
received:
08
11
2023
accepted:
24
01
2024
medline:
21
3
2024
pubmed:
21
3
2024
entrez:
21
3
2024
Statut:
epublish
Résumé
Post-contrast acute kidney injury is defined as a nephropathy with an increase in serum creatinine of >0.3 mg/dL (or >26.5 μmol/L) or >1.5-times the baseline within 48-72 h of intravascular administration of a contrast medium. Patients with cancer have an increased risk of post-contrast acute kidney injury not only related to the frequent use of contrast medium for computed tomography scans but also to other factors, including the type of tumour, age, oncological therapies, use of other nephrotoxic agents and dehydration. Preventive strategies were developed and may be applied to different risk profiles. Patients at risk may be detected by recently published risk scores.
Identifiants
pubmed: 38510312
doi: 10.7573/dic.2023-11-2
pii: dic-2023-11-2
pmc: PMC10954291
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Informations de copyright
Copyright © 2024 Grassedonio E, Incorvaia L, Guarneri M, Guagnini F, Midiri M.
Déclaration de conflit d'intérêts
Disclosure and potential conflicts of interest: FG is an employee of GE HealthCare, Pharmaceutical Diagnostics (PDx), Milan, Italy. The other authors have no conflicts to declare. The International Committee of Medical Journal Editors (ICMJE) Potential Conflicts of Interests form for the authors is available for download at: https://www.drugsincontext.com/wp-content/uploads/2024/02/dic.2023-11-2-COI.pdf